166 related articles for article (PubMed ID: 18513421)
1. Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report.
Quan Y; Brenner BG; Dascal A; Wainberg MA
Retrovirology; 2008 May; 5():43. PubMed ID: 18513421
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.
Paolucci S; Baldanti F; Campanini G; Zavattoni M; Cattaneo E; Dossena L; Gerna G
J Med Virol; 2001 Oct; 65(2):207-17. PubMed ID: 11536225
[TBL] [Abstract][Full Text] [Related]
3. Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.
Verhofstede C; Noë A; Demecheleer E; De Cabooter N; Van Wanzeele F; Van Der Gucht B; Vogelaers D; Plum J
J Acquir Immune Defic Syndr; 2004 Apr; 35(5):473-83. PubMed ID: 15021312
[TBL] [Abstract][Full Text] [Related]
4. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.
Bon I; Alessandrini F; Borderi M; Gorini R; Re MC
New Microbiol; 2007 Jul; 30(3):313-7. PubMed ID: 17802917
[TBL] [Abstract][Full Text] [Related]
6. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.
Monno L; Punzi G; Scarabaggio T; Saracino A; Brindicci G; Fiore JR; Iambrenghi OC; Di Stefano M; Pastore G; Angarano G
J Med Virol; 2003 May; 70(1):1-9. PubMed ID: 12629636
[TBL] [Abstract][Full Text] [Related]
7. Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year.
Bi X; Gatanaga H; Ida S; Tsuchiya K; Matsuoka-Aizawa S; Kimura S; Oka S
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):1-6. PubMed ID: 14501787
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
9. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.
Bon I; Gibellini D; Borderi M; Alessandrini F; Vitone F; Schiavone P; Re MC
J Clin Virol; 2007 Apr; 38(4):313-20. PubMed ID: 17306618
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India.
Sen S; Tripathy SP; Chimanpure VM; Patil AA; Bagul RD; Paranjape RS
AIDS Res Hum Retroviruses; 2007 Apr; 23(4):489-97. PubMed ID: 17506605
[TBL] [Abstract][Full Text] [Related]
11. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients.
Devereux HL; Loveday C; Youle M; Sabin CA; Burke A; Johnson M
AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1025-30. PubMed ID: 10933616
[TBL] [Abstract][Full Text] [Related]
12. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
Usuku S; Noguchi Y; Sakamoto M; Adachi T; Sagara H; Sudo K; Nishizawa M; Kondo M; Tochikubo O; Imai M
Jpn J Infect Dis; 2006 Apr; 59(2):122-5. PubMed ID: 16632914
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
[TBL] [Abstract][Full Text] [Related]
15. Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase.
Chen L; Perlina A; Lee CJ
J Virol; 2004 Apr; 78(7):3722-32. PubMed ID: 15016892
[TBL] [Abstract][Full Text] [Related]
16. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.
Ghosn J; Viard JP; Katlama C; de Almeida M; Tubiana R; Letourneur F; Aaron L; Goujard C; Salmon D; Leruez-Ville M; Rouzioux C; Chaix ML
AIDS; 2004 Feb; 18(3):447-57. PubMed ID: 15090797
[TBL] [Abstract][Full Text] [Related]
17. HIV-1C proviral DNA for detection of drug resistance mutations.
Huruy K; Mulu A; Liebert UG; Maier M
PLoS One; 2018; 13(10):e0205119. PubMed ID: 30286160
[TBL] [Abstract][Full Text] [Related]
18. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
[TBL] [Abstract][Full Text] [Related]
19. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.
Yahi N; Tamalet C; Tourrès C; Tivoli N; Ariasi F; Volot F; Gastaut JA; Gallais H; Moreau J; Fantini J
J Clin Microbiol; 1999 Dec; 37(12):4099-106. PubMed ID: 10565938
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
